Prostatic Diseases  >>  Tookad (padeliporfin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tookad (padeliporfin) / ImPact Biotech
NCT00707356 / 2008-000876-26: Study of WST11 in Patients With Localized Prostate Cancer

Completed
2
42
Canada, Europe
WST11, WST11-mediated VTP
Steba Biotech S.A.
Prostate Cancer
01/11
07/12
NCT00975429 / 2009-012809-19: Study Using WST11 in Patients With Localized Prostate Cancer

Completed
2
86
Europe
WST11, Treatment with WST11-mediated VTP
Steba Biotech S.A.
Prostate Cancer
12/11
08/12
NCT00946881: Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer

Completed
1/2
30
US
WST 11 -mediated -VTP, TOOKAD Soluble
Steba Biotech S.A.
Prostate Cancer
07/12
08/12

Download Options